A Randomised Dose Escalation Study of Subcutaneous Interleukin 2 With and Without Levamisole in Patients With Metastatic Renal Cell Carcinoma or Malignant Melanoma
British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1996.498
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 1996
Authors
Publisher
Springer Science and Business Media LLC